CD080524130 Khushboo Eb26

Name : MRS. KHUSHBOO Patient UID.
: P48143949
Visit No. : CD080524130 Registered on : 08/05/2024 16:22
Age/Gender : 34 Y / Female Collected on : 08/05/2024 16:23
Referred Client : NORTHERN RAILWAY HEALTH UNIT Approved on : 09/05/2024 18:24
Referred by : N/A Barcode No : 080524130
Doctor Name : FARIDABAD
CLINICAL BIOCHEMISTRY
Test Name Results Units Bio. Ref. Interval
CA 125 [ OVARIAN CANCER MARKER ] 12.80 U/mL 0 - 35
Methodology : Chemiluminescent Microparticle Immunoassay(CMIA)
Interpretation Notes :
1. This test is not recommended to screen Ovarian cancer in the general population.
2. False negative / positive results are observed in patients receiving mouse monoclonal antibodies for diagnosis or therapy
3. Patients with confirmed Ovarian cancer may show normal pre-treatment CA 125 levels. Hence this assay, regardless of level, should not be interpreted as absolute evidence
for the presence or absence of malignant disease. The assay value should be used in conjunction with findings from clinical evaluation and other diagnostic procedures.
4. The results obtained with different analytical techniques and different equipments cannot be used interchangeably due to difference in assay methods and reagent specificity.
5. In course of monitoring, the assay method preferably should not be changed.
* CA 125 present on the surface of most ovarian cancer cells, is an useful assay for monitoring the course of disease in invasive epithelial ovarian cancer.
* Not useful in some types of ovarian cancers that do not produce CA125(baseline levels of CA 125 are normal in such cases).
* Persistently high values may indicate a poor response to therapy.
* Serial and periodic assessments are helpful in diagnosing recurrence.
* A low value does not rule out absence of residual ovarian tumor.
Increased levels: Primary epithelial ovarian carcinoma, Healthy individuals (1-2 %), First trimester of pregnancy, Follicular phase of menstrual cycle.
Non malignant conditions : Cirrhosis, Hepatitis, Endometriosis, Ovarian cysts, Pelvic Inflammatory disease Non Ovarian malignancies - Endometrial, Pancreatic, Lung, Breast,
Colorectal & other Gastrointestinal tumors.
DISCLAIMER : Sample Processed in Referral lab.
CALCIUM - SERUM 8.4 mg/dL 8.4 - 10.2

Methodology : Arsenazo dye
A blood calcium test is ordered to screen for, diagnose, and monitor a range of conditions relating to the bones, heart, nerves, kidneys, and teeth. The test may also be ordered if
a person has symptoms of a parathyroid disorder, malabsorption, or an overactive thyroid.A total calcium level is often measured as part of a routine health screening. It is
included in the comprehensive metabolic panel (CMP) and the basic metabolic panel (BMP), groups of tests that are performed together to diagnose or monitor a variety of
conditions.When an abnormal total calcium result is obtained, it is viewed as an indicator of an underlying problem. To help diagnose the underlying problem, additional tests
are often done to measure ionized calcium, urine calcium, phosphorus, magnesium, vitamin D, parathyroid hormone (PTH) and PTH-related peptide (PTHrP). PTH and vitamin
D are responsible for maintaining calcium concentrations in the blood within a narrow range of values.If the calcium is abnormal, measuring calcium and PTH together can help
determine whether the parathyroid glands are functioning normally. Measuring urine calcium can help determine whether the kidneys are excreting the proper amount of
DR.NEETA SETH
M.B.B.S, MD (PATH.)
Page 1 of 9 SENIOR PATHOLOGIST
Name : MRS. KHUSHBOO Patient UID. : P48143949
calcium, and testing for vitamin D, phosphorus, and/or magnesium can help determine whether other deficiencies or excesses exist. Frequently, the balance among these
different substances (and the changes in them) is just as important as the concentrations.
RHEUMATOID FACTOR [ RA FACTOR ] ( QUANTITATIVE ) 10.0 IU/mL 0.0 - 18.0

Methodology : Nephelometry
Rheumatoid factor (RF) is an autoantibody, an immunoglobulin IgM that is produced by the body's immune system. Autoantibodies attack a person's own tissues, mistakenly
identifying the tissue as "foreign." While the biologic role of RF is not well understood, its presence is useful as an indicator of inflammatory and autoimmune activity. This test
detects and measures RF in the blood and may be used, along with other tests, to help in the diagnose of Rheumatoid Arthritis (RA).RA is a chronic systemic autoimmune
disease that causes inflammation, pain, stiffness, and destructive changes in the hands, feet, and other joints throughout the body. Some patients may show signs of fatigue, low-
grade fevers, and weight loss. Rheumatoid factor has been used to detect RA. Because the sensitivity and specificity of RF are not ideal, other laboratory tests are often
performed in conjunction with RF testing. About 80% of those with RA will have a positive RF test, but it can be negative in people who have clinical signs of RA.
Elevated RF can be found in a small percentage (5-10%) of healthy people. RF may also be elevated in the elderly, though they may not demonstrate clinical signs. In addition,
elevated levels of RF may be detected in people who do not have RA (false positive) but may have another disorder:
· Sjogren syndrome
· Systemic lupus erythmatosus
· Bacterial, viral and parasitic infections (hepatitis, TB, syphilis, leprosy)
· Certain cancers
· Lung disease, liver disease, and kidney disease
URIC ACID - SERUM 3.3 mg/dL 2.5 - 6.2
Methodology : URICASE POD
Primary Sample Type : SERUM
DR.NEETA SETH
M.B.B.S, MD (PATH.)
LIVER FUNCTION TEST.
TOTAL BILIRUBIN 0.23 mg/dL 0.2 - 1.3

Methodology : Azobilirubin/Dyphyllime
DIRECT BILIRUBIN 0.08 mg/dL <0.3
Methodology : Calculated
INDIRECT BILIRUBIN 0.15 mg/dL 0 - 0.6
Methodology : Spectrophotometry
SGOT (AST) 42 U/L <31
Methodology : Kinetic with Pyridoxal 5 Phosphate
SGPT (ALT) 48 U/L <34
Methodology : Kinetic with Pyridoxal 5 Phosphate
ALKALINE PHOSPHATASE (ALP) 88 U/L 38 - 126
Methodology : Para nitrophenyl phosphate, AMP buffer
Interpretation:
A liver panel may be used to screen for liver damage, especially if someone has a condition or is taking medications that may affect the liver. This group of tests includes most
of the liver panel as well as additional tests that evaluate other organs and systems within the body. If a person has a known condition or liver disease, testing may be performed
at intervals to monitor the health of the liver and to evaluate the effectiveness of any treatments. A series of bilirubin tests, for instance, may be ordered to evaluate and monitor a
jaundiced newborn. Abnormal tests on a liver panel may prompt a repeat analysis of one or more tests, or of the whole panel, to see if the elevations or decreases persist and/or
may indicate the need for additional testing to determine the cause of the liver dysfunction.
DR.NEETA SETH
M.B.B.S, MD (PATH.)
KIDNEY FUNCTION TEST..
BLOOD UREA 15 mg/dL 15 - 36

Methodology : Urease with indicator dye
SERUM CREATININE 0.5 mg/dL 0.5 - 1.0
Methodology : Enzymatic(creatinine amidohydrolase)
URIC ACID - SERUM 3.3 mg/dL 2.5 - 6.2
Methodology : URICASE POD
SODIUM - SERUM 138 mmol/L 136 - 145
Methodology : ISE-DIRECT
POTASSIUM - SERUM 4.1 mmol/L 3.5 - 5.1
CHLORIDE - SERUM 101 mmol/L 98 - 107
DR.NEETA SETH
M.B.B.S, MD (PATH.)
CLINICAL PATHOLOGY
URINE ROUTINE EXAMINATION ; URINE, R/E
PHYSICAL EXAMINATION
Urine colour PALE YELLOW
Urine Appearance Clear
CHEMICAL EXAMINATION
Urine pH 5.0 5.0 - 7.0
Specific Gravity 1.015 1.005 - 1.030
Urine Protein NIL NIL
Urine Glucose NIL NIL
MICROSCOPIC EXAMINATION
Urine Pus Cells 1-2 /HPF 0 - 5/HPF
Epithelial Cells 6-10 /HPF 0 - 5/HPF
Urine RBC cells NIL /HPF NIL/HPF
Casts NIL NIL / LPF
Crystals NIL NIL/HPF
Bacteria Present ++ NIL/HPF
Other NIL
Primary Sample Type : URINE
DR. PANKAJ TAYAL

M.B.B.S. DNB (PATH.)
Page 5 of 9 Consultant Pathologist
HAEMATOLOGY
COMPLETE BLOOD COUNT (CBC)
HAEMOGLOBIN (Hb) 11.9 g/dl 12 - 15

Methodology : Non-cyanide/ colorimetric
TOTAL LEUCOCYTE COUNT (TLC) 6.6 10^3/µL 4 - 10
Methodology : Flow Cytometry
PLATELET COUNT (PC) 191 10^3/µL 150 - 410
Methodology : Electrical Impedance/Microscopy
DIFFERENTIAL LEUCOCYTE COUNT (DLC)
Neutrophils 72 % 40 - 80
Methodology : Flow Cytometry/Microscopy
Lymphocytes 25 % 20 - 40
Eosinophils 01 % 1-6
Monocytes 02 % 2 - 10
Basophils 00 % 0-2
RED BLOOD CELL COUNT (RBC) 3.96 10^6 /µL 3.8 - 4.8
Methodology : Electrical Impedence
PACKED CELL VOLUME/HEMATOCRIT (PCV) 36.5 % 36 - 46
MEAN CORPUSCULAR VOLUME (MCV) 92.17 fL 83 - 101
MEAN CORPUSCULAR HAEMOGLOBIN (MCH) 30.05 pg 27 - 32
MCH CONCENTRATION (MCHC) 32.60 g/dl 31.5 - 34.5
Primary Sample Type : WHOLE BLOOD-EDTA
DR.NEETA SETH
M.B.B.S, MD (PATH.)
HAEMATOLOGY
COMPLETE BLOOD COUNT (CBC)
RED CELL DISTRIBUTION WIDTH (RDW-CV) 11.8 % 11 - 16.7

Primary Sample Type : WHOLE BLOOD-EDTA
DR.NEETA SETH
M.B.B.S, MD (PATH.)
IMMUNOLOGY
VITAMIN D, 25 HYDROXY 11.5 ng/mL Deficiency - < 20
Insufficiency - 20- <30
Sufficiency. - 30-100
Toxicity - >100
Methodology : ECLIA
Vitamin D is a family of compounds that is essential for the proper growth and formation of teeth and bones. This test measures the level of vitamin D in the
blood. Two forms of vitamin D can be measured in the blood, 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D. The 25-hydroxyvitamin D is the major form
found in the blood and is the relatively inactive precursor to the active hormone, 1,25-dihydroxyvitamin D. Because of its long half-life and higher concentration,
25-hydroxyvitamin D is commonly measured to assess and monitor vitamin D status in individuals. A vitamin D test is used to:Determine if bone weakness, bone
malformation, or abnormal metabolism of calcium (reflected by abnormal calcium, phosphorus, PTH) is occurring as a result of a deficiency or excess of vitamin
DHelp diagnose or monitor problems with parathyroid gland functioning since PTH is essential for vitamin D activationScreen people who are at high risk of
deficiency, as recommended by the National Osteoporosis Foundation, the Institute of Medicine, and the Endocrine SocietyHelp monitor the health status of
individuals with diseases that interfere with fat absorption, such as cystic fibrosis and Crohn disease, since vitamin D is a fat-soluble vitamin and is absorbed
from the intestine like a fatMonitor people who have had gastric bypass surgery and may not be able to absorb enough vitamin DHelp determine the
effectiveness of treatment when vitamin D, calcium, phosphorus, and/or magnesium supplementation is prescribed.
DR.NEETA SETH
M.B.B.S, MD (PATH.)
IMMUNOLOGY
THYROID STIMULATING HORMONE (TSH) 2.03 uIU/mL 0.46 - 4.68
Pregnancy
First trimester : 0.30 - 4.50
Second trimester : 0.50 - 4.60
Third trimester : 0.80 - 5.20
Methodology : ECLIA
The thyroid-stimulating hormone (TSH) test is often the test of choice for evaluating thyroid function and/or symptoms of a thyroid disorder, including hyperthyroidism or
hypothyroidism.TSH is produced by the pituitary gland, a tiny organ located below the brain and behind the sinus cavities. It is part of the body's feedback system to maintain
stable amounts of the thyroid hormones thyroxine (T4) and triiodothyronine (T3) in the blood and to help control the rate at which the body uses energy.A TSH test is frequently
ordered along with or preceding a free T4 test. Other thyroid tests that may be ordered include a free T3 test and thyroid antibodies (if autoimmune-related thyroid disease is
suspected). Sometimes TSH, free T4 and free T3 are ordered together as a thyroid panel.
*** End of Report ***

All tests have technical limitations.Collaborative clicnicopathological interpretation is mandatory. Isolated lab investigation may not confirm diagnosis of
disease. In case of Unexpected/alarming results,doctor/patient is advised to contact lab immediately for necessary action.
Processed By: RANJEET

Verified by : DR.NEETA SETH
DR.NEETA SETH
M.B.B.S, MD (PATH.)

CD080524130 Khushboo Eb26

Uploaded by

Copyright:

Available Formats

CD080524130 Khushboo Eb26

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

CD080524130 Khushboo Eb26

Uploaded by

Copyright:

Available Formats

Name : MRS. KHUSHBOO Patient UID.

5. In course of monitoring, the assay method preferably should not be changed.

* Persistently high values may indicate a poor response to therapy.

* Serial and periodic assessments are helpful in diagnosing recurrence.

DISCLAIMER : Sample Processed in Referral lab.

CALCIUM - SERUM 8.4 mg/dL 8.4 - 10.2

RHEUMATOID FACTOR [ RA FACTOR ] ( QUANTITATIVE ) 10.0 IU/mL 0.0 - 18.0

Primary Sample Type : SERUM

TOTAL BILIRUBIN 0.23 mg/dL 0.2 - 1.3

Primary Sample Type : SERUM

BLOOD UREA 15 mg/dL 15 - 36

Primary Sample Type : SERUM

Primary Sample Type : URINE

DR. PANKAJ TAYAL

HAEMOGLOBIN (Hb) 11.9 g/dl 12 - 15

Primary Sample Type : WHOLE BLOOD-EDTA

RED CELL DISTRIBUTION WIDTH (RDW-CV) 11.8 % 11 - 16.7

Primary Sample Type : WHOLE BLOOD-EDTA

Primary Sample Type : SERUM

Primary Sample Type : SERUM

*** End of Report ***

Processed By: RANJEET

You might also like

* End of Report *